[Breaking] Samhyun (437730) Surges 19% in After-Hours NXT Trading, Recovering '30,000 Won Level'... Robot Stocks Rally
Samhyun (437730) significantly expanded its gains in after-hours trading (NXT) on the 21st, recovering the 30,000-won level. As of 6:04 p.m. on this day, Samhyu
![[Breaking] Samhyun (437730) Surges 19% in After-Hours NXT Trading, Recovering '30,000 Won Level'... Robot Stocks Rally](/_next/image?url=https%3A%2F%2Fmedia.cbcglobe.com%2Ftenants%2Fcbc00000-0000-4000-8000-000000000001%2Fmedia%2Fcbc%2F2026%2F06%2F581419%2F479dac739b049517%2Foriginal.webp&w=1920&q=75)
Samhyun (437730) significantly expanded its gains in after-hours trading (NXT) on the 21st, recovering the 30,000-won level.
As of 6:04 p.m. on this day, Samhyun is trading at 31,700 won in the NXT after-hours market, surging 5,100 won (19.17%) compared to the regular session closing price (28,100 won). Samhyun had closed the regular session up 1,500 won (5.64%) from the previous trading day at 28,100 won, but as trading moved to the after-hours market, buying momentum strengthened further, pushing the stock above the 30,000-won threshold.
Samhyun, which possesses electric actuator and motor control technology—core components in the automotive, robotics, and defense sectors—rose in tandem with growing expectations for the robotics industry. In particular, the news that Samsung Electronics had established a new robot business organization, reported in the domestic stock market on this day, led to broad strength in robotics-related stocks, which served to bolster positive investor sentiment.
The strong performance from the regular session carried over directly into the after-hours NXT market, driving Samhyun's stock price gains. However, since NXT trading takes place in the after-hours market following the close of the regular session, attention is focused on whether this upward momentum will extend into the next trading day's regular session.
[This article is not intended to solicit investment. All final investment decisions and responsibilities rest solely with the investor.]
CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.
![[Breaking] April Bio Signs License-in Agreement with Qurigen for Dual-Target siRNA Metabolic Disease Therapeutics](/_next/image?url=https%3A%2F%2Fmedia.cbcglobe.com%2Ftenants%2Fcbc00000-0000-4000-8000-000000000001%2Fmedia%2Fcbc%2F2026%2F06%2F579783%2F4e4da2bfb8f012b9%2Fvariants%2Fhero.webp&w=1920&q=75)

![[Breaking] KakaoPay Surges 7.68% in After-Hours NXT Trading... Buying Expands as It Recovers 40,000-Won Level in Regular Session](/_next/image?url=https%3A%2F%2Fmedia.cbcglobe.com%2Ftenants%2Fcbc00000-0000-4000-8000-000000000001%2Fmedia%2Fcbc%2F2026%2F06%2F581911%2Fa630da1c47d6049c%2Fvariants%2Fhero.webp&w=1920&q=75)